arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Eledon Pharmaceuticals, Inc.

ELDN

$3.69 ▲ +0.25 (+7.11%) at close

15 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Eledon Pharmaceuticals, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $302.0M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC None

FCF / Share $-0.76 ↗

Trailing P/E —

Price / Book 3.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-45.62M

↓ -26.1% —

FCF / Share Free cash flow per share

$-0.76

↑ +21.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
EPS Growth YoY (%)	21.2% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	59.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	73.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-164.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-26.1% Weak ↑ Weak Improving Year-over-year change in net income	10.3% Fair ↑ Fair Improving Year-over-year change in net income	54.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-154.9% Weak ↓ Weak Declining Year-over-year change in net income	-51.3% Weak ↓ Weak Declining Year-over-year change in net income	-42.5% Weak ↓ Weak Declining Year-over-year change in net income	-13.8% Weak ↓ Weak Declining Year-over-year change in net income	-7.2% Weak ↓ Weak Declining Year-over-year change in net income	65.4% Excellent ↑ Excellent Improving Year-over-year change in net income	15.8% Good ↑ Good Improving Year-over-year change in net income	-93.5% Weak ↓ Weak Declining Year-over-year change in net income	-48.1% Weak Weak Year-over-year change in net income	-63.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	21.8% Good ↑ Good Improving Year-over-year change in free cash flow	39.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	19.3% Good Good Year-over-year change in free cash flow	-2.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Effective Tax Rate (%) (%)	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	—	—	-51.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-105.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-134.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-76.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-53.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-112.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	22.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	19.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	—	—	-48.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-95.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-146.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-82.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-62.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-128.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-66.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-48.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-56.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-475%)	-57.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-486%)	-48.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-422%)	-104.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-797%)	-21.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-12.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-169.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1228%)	-97.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-747%)	-67.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-550%)	-141.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1042%)	-73.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-587%)	-22.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	28.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+90%)	24.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+61%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Net Debt (USD)	$-22.81M	$-20.55M	$-4.61M	$-56.41M	$-84.83M	$-114.19M	$-8.79M	$-12.97M	$-17.23M	$-23.22M	$-24.02M	$-105.26M	$-31.75M	$-11.69M	$-2.25M

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Basic EPS, GAAP (USD)	$-0.52	$-0.66	$-1.64	$-6.16	$-2.33	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.76	$-0.97	$-1.61	$-1.99	$-1.95	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.07	$1.04	$3.45	$6.11	$11.46	$12.57	$13.14	$27.69	$49.24	$192.17	$442.50	$749.12	—	—	—
Tangible Book Value per Share (USD)	$1.07	$1.04	$3.45	$6.11	$8.06	$9.36	$13.14	$24.12	$44.52	$192.17	$442.50	$749.12	—	—	—
Basic Weighted Avg Shares (shares)	81.84M	48.54M	24.62M	14.29M	14.82M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$117.34M	$132.15M	$52.23M	$53.04M	$83.94M	$113.15M	$8.65M	$11.74M	—	$26.72M	$61.01M	$103.27M	$29.97M	—	—
Total Equity (USD)	$81.08M	$62.45M	$83.42M	$84.18M	$164.00M	$190.60M	$9.46M	$14.49M	$19.45M	$26.86M	$61.72M	$103.50M	$-55.27M	$-39.90M	$-30.43M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	—
Depreciation Expense (USD)	—	—	—	—	—	—	—	—	—	$171.00K	$109.00K	$21.00K	$10.00K	$9.00K	—
Net Income, GAAP (USD)	$-45.62M	$-36.18M	$-40.33M	$-87.97M	$-34.51M	$-22.81M	$-16.01M	$-14.06M	$-13.12M	$-37.96M	$-45.09M	$-23.30M	$-15.72M	$-9.65M	—
Operating Cash Flow (USD)	$-62.34M	$-47.27M	$-39.53M	$-28.42M	$-28.91M	$-15.21M	$-13.86M	$-11.89M	$-14.94M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 54 quarters

Eledon Pharmaceuticals, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ELDN with peers